AUSTIN, Texas--(BUSINESS WIRE)---- $EMPD #BTC--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today announced that since the last update on August 6, 2025, the Company has acquired an additional 17.51 BTC for a total purchase price of $2.0 million. As of the time of this release, the Company holds 4,018.36 BTC acquired for an aggregate purchase price of approximately $472 million, reflecting an average purchase price of $117,552 per BTC. Additionally, the Company today announced that i.

WAYZATA, Minn.--(BUSINESS WIRE)--MCVT (NASDAQ: MCVT) (the "Company" or "MCVT"). Key Highlights: Treasury: MCVT held 81,871,794 SUI as of August 10, 2025. Since last update 5,600,607 SUI have been purchased at an average price of $3.65 per SUI. Net Asset Value: Using the August 10, 2025 price of $3.85 per SUI, the 81,871,794 SUI are valued at $316 million. SUI per Share: Using 89.08 million shares issued and outstanding on August 10, 2025, MCVT has approximately 0.92 SUI per common share, or $3.

CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT.

NEWTOWN SQUARE, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the second quarter ended June 30, 2025, and highlighted recent Company progress.

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab monotherapy, HR=0.77 (CI 0.58-1.00), (p=0.056), with median PFS (mPFS) of 19.4 months vs. 11.0 months, respectively; the results on the primary endpoint narrowly missed the study's statistical significance threshold of p≤0.045 In patients enrolled in this study without prior neo-adjuvant/adjuvant anti-PD-1 treatment (n=371), patients treated with Cylembio plus pembrolizumab achieved improvement in PFS, HR: 0.74 (CI 0.56-0.98) (nominal p=0.037), with mPFS of 24.8 months vs.

CENTER VALLEY, Pa. & KENT, Wash.--(BUSINESS WIRE)--Shift4 Payments, Inc. (“Shift4”) (NYSE: FOUR), the leader in integrated payments and commerce technology, and Blue Origin, the pioneering space exploration company, are working together to enable customers to pay in cryptocurrency and stablecoins for trips to space. Starting today and powered by Shift4's seamless payments technology, consumers can pay with popular cryptocurrencies and stablecoins like Bitcoin, Ethereum, Solana, USDT and USDC fo.

FREMONT, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the IQ® Battery 5P™ with FlexPhase for customers in Australia. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase and three-phase applications with variable power levels, offering flexibility to meet diverse home energy needs.

Beijing, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Mr. Yu He, Chairman of Beijing KUKE Music Co., Ltd.

MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company's outstanding shares of common stock.

Granted Patent Covers Neural Measurement of Weight, Torque and Force with Broad Applications in Brain-Computer Interfaces, Industry 4.0 and Extended Reality YOKNEAM ILLIT, ISRAEL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced that the United States Patent and Trademark Office has officially granted the Company's patent titled “Gesture and Voice-Controlled Interface Device.

BOISE, Idaho, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) (the “Company”) today announced that it is updating its revenue, gross margin, operating expense, and EPS guidance for the fourth quarter of fiscal 2025, which ends August 28, 2025. The Company previously provided guidance for revenue of $10.7 billion ± $300 million, non-GAAP gross margins of 42.0% ± 1.0%, and non-GAAP EPS of $2.50 ± $0.15 for the fourth quarter of fiscal 2025.

TEMPE, Ariz.--(BUSINESS WIRE)--Benchmark Electronics, Inc. (NYSE: BHE) proudly announces the successful completion of the delivery of 24 Mobile Vehicle Surveillance Systems with Radar (MVSS-R) for U.S. Customs and Border Protection (CBP) and the Federal Aviation Administration (FAA). This delivery, completed on time and within budget, reaffirms Benchmark's commitment to excellence in developing and deploying advanced surveillance technology that leverages artificial intelligence (AI), radar, an.

PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal Therapeutics reports on Second Quarter 2025 financial results and provides corporate update on strategic clinical trial plans.

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI) (“Pitney Bowes” or, the “Company”) today announced that it completed its previously announced offering (the “Offering”) of $230 million aggregate principal amount of 1.50% convertible senior notes due 2030 (the “Convertible Notes”) in a private placement under the Securities Act of 1933, as amended (the “Securities Act”). The $230 million aggregate principal amount of Convertible Notes sold in the Offering includes $30 million aggre.

NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) today announced that its President and Chief Operating Officer, John Bruno, has decided to pursue a CEO opportunity outside of Xerox. Bruno, who has served as President and COO since 2022 and as a Xerox Board member since 2024, will remain in his operating role through August 31, and then continue as a member of the Xerox Board of Directors. In his Board member role, he will chair the newly formed Integration Committee, o.

NEW YORK--(BUSINESS WIRE)--WisdomTree today released monthly metrics for July 2025, including assets under management (AUM) and flow data by asset class.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the early tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase any and all of the Issuer's outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2025, as ame.

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a global advisory, broking and solutions company, has today announced the appointment of Nicholas Carbo as Senior Director to its Insurance Consulting & Technology (ICT) business.

PARSIPPANY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the second quarter ended June 30, 2025, as well as recent business developments.

DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crestone Air Partners (“Crestone”) today announced the formation of Blue Crest Aviation Partners (“Blue Crest”), a new joint venture anchored by funds managed by Blue Owl Capital, Inc. (“Blue Owl”). The platform will seek to acquire mid-life commercial jet aircraft on lease to airlines globally, through a disciplined, income-oriented strategy.